Encompass Health Corp
NYSE:EHC
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
66.72
103.77
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Wall Street
Price Targets
EHC Price Targets Summary
Encompass Health Corp
According to Wall Street analysts, the average 1-year price target for EHC is 118.83 USD with a low forecast of 111.1 USD and a high forecast of 131.25 USD.
EHC Last Price Targets
Encompass Health Corp
The latest public price target was made on Sep 26, 2024 by Ben Hendrix from RBC Capital , who expects EHC stock to rise by 11% over the next 12 months. You can read more about this price target by viewing the article on TheFly.
Analyst | Price Target | Date | Article |
---|---|---|---|
Ben Hendrix
RBC Capital
|
105
USD
Upside 11% |
3 months ago
Sep 26, 2024
|
Encompass Health price target raised to $105 from $95 at RBC Capital
TheFly
|
AJ Rice
UBS
|
110
USD
Upside 17% |
3 months ago
Sep 25, 2024
|
Encompass Health price target raised to $110 from $100 at UBS
TheFly
|
Frank Morgan
RBC Capital
|
95
USD
Upside 1% |
7 months ago
May 22, 2024
|
Encompass Health Corp (EHC) PT Raised to $95 at RBC Capital
StreetInsider
|
Ann Hynes
Mizuho Securities
|
95
USD
Upside 1% |
8 months ago
Apr 25, 2024
|
Encompass Health Corp (EHC) PT Raised to $95 at Mizuho
StreetInsider
|
Andrew Mok
Barclays
|
101
USD
Upside 7% |
8 months ago
Mar 28, 2024
|
Encompass Health Corp (EHC) PT Raised to $101 at Barclays
StreetInsider
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is EHC's stock price target?
Price Target
118.83
USD
According to Wall Street analysts, the average 1-year price target for EHC is 118.83 USD with a low forecast of 111.1 USD and a high forecast of 131.25 USD.
What is Encompass Health Corp's Revenue forecast?
Projected CAGR
10%
For the last 8 years the compound annual growth rate for Encompass Health Corp's revenue is 6%. The projected CAGR for the next 3 years is 10%.
What is Encompass Health Corp's Operating Income forecast?
Projected CAGR
10%
For the last 8 years the compound annual growth rate for Encompass Health Corp's operating income is 4%. The projected CAGR for the next 3 years is 10%.
What is Encompass Health Corp's Net Income forecast?
Projected CAGR
11%
For the last 8 years the compound annual growth rate for Encompass Health Corp's net income is 9%. The projected CAGR for the next 4 years is 11%.